gentle
Developer of an at-home neurostimulation platform that combines a wearable headband and mobile app to deliver low-intensity transcranial direct current stimulation (tDCS) for daily support of calm, focus, and sleep. Publishes scientific content, references peer-reviewed literature, and provides customer support and a 30-day home trial.
Industries
Nr. of Employees
small (1-50)
gentle
2418 Lombard St., San Francisco, CA 94123, United States
Products
Neurostimulation headband
Wearable headband that delivers low‑intensity tDCS for app‑guided sessions; sold with starter single‑use pads, charging cable, and app access.
Scientific blog and evidence summaries
Published articles summarizing mechanisms, safety, and efficacy evidence for tDCS, referencing peer-reviewed meta-analyses and RCTs.
Consumable pads
Single-use electrode pads supplied with the headband; refills available via app.
NewsList
News and updates
Company maintains a scientific blog with dated posts summarizing evidence and safety of tDCS.
Return policy
30-day home trial and documented return eligibility criteria.
Contact channels
Public email and phone contact for customer support and clinician/research inquiries.
Scientific blog articles
Selected recent blog posts on tDCS mechanism, safety, efficacy, and adherence.
People and contacts
Named individuals listed in blog and contact pages available for inquiries and scientific contributions.
Company address
Physical mailing address for the company.
Social profiles
Official social media channels for science and design updates.
Support & policies
Customer support, returns, and trial policies documented online.
Research references
References to peer‑reviewed meta-analyses and randomized controlled trials used in blog content.
Regulatory and safety guidance
Public guidance on safety, contraindications, and appropriate candidates for tDCS use.
Commercial offering
Direct-to-consumer sales of a neurostimulation headband and associated consumables.
Educational content
Blog content and FAQs that explain mechanisms, safety, and appropriate use of tDCS.
FAQs
Documented frequently asked questions covering kit contents, usage, safety, and contraindications.
Return and refund handling
Operational processes for inspecting returns and issuing refunds within specified timelines.
Customer communication
Multiple contact channels including email and phone for support and inquiries.
Device price and purchase terms
Retail pricing information and purchase terms including trial and shipping details.
Safety contraindications
Explicit contraindications for use (e.g., implanted electronic devices, epilepsy, heart conditions, under 18, pregnancy caution).
Clinical summaries
Summaries of clinical trial evidence and meta-analyses on tDCS efficacy for depression.
Adherence guidance
Guidance on building routine and improving adherence for at‑home tDCS treatment.
Clinical contact email
Designated email for clinician, research, and customer support inquiries.
Shipping and logistics
Free US shipping offered; international returns have specified responsibilities.
Clinical advisement
Engagement of clinical advisors and contributors to blog content.
Research citations
Reference list pointing to specific peer-reviewed publications and RCTs in blog posts.
FAQ documentation
Publicly documented FAQs covering how to use the device, safety, contraindications, and refill ordering.
Community features (roadmap)
Planned features such as reminders and community support mentioned as upcoming in personalization content.
Clinical evidence translation
Effort to translate clinical trial protocols and evidence into consumer-facing treatments and guidance.
Safety and contraindications documentation
Published safety guidance and contraindication lists to inform appropriate use.
Home-use deployment model
Operational model supporting direct consumer sales, home trials, and remote support for device deployment.
Clinical content authorship
Medical students and clinicians contribute authored blog posts and educational content.
Device ordering and checkout
Online storefront with purchase flow, financing options, and order management.
Device shipping policies
Shipping and international return terms documented for purchasers.
Regulatory posture and safety emphasis
Public emphasis on safety, appropriate candidate selection, and adherence to clinically tested stimulation parameters.
Educational and onboarding materials
Quick-start guides and onboarding instructions provided with the device and via the app.
App-managed refill ordering
In-app purchase flow for consumable pad refills.
Clinical advisory involvement
Named clinical contributors and advisors participate in content and product guidance.
Published blog articles
List of recent scientific blog posts on mechanism, safety, efficacy, and adherence.
Support response timeframe
Typical customer support response within one business day stated on contact page.
Company mailing address
Listed corporate mailing address in San Francisco, CA.
Safety contraindications and exclusions
Documented contraindications for device use, e.g., implanted devices, seizure history, serious heart conditions, age restrictions.
Financing options
Flexible payment options and financing for device purchases.
Documentation of trials and cohorts
Statements indicating shipment to an initial cohort and use in early adopters.
Consumer-facing educational materials
FAQs, quick-start guides, and blog posts to explain device use and tDCS concepts.
Clinical evidence references
References to meta-analyses and RCTs in support of tDCS efficacy claims for depression.
Adherence and usability design
Design emphasis on comfort, ease of use, and integration into daily routine to support long‑term adherence.
Device packaging and included items
Headband kits include device, starter pads, charging cable, and quick-start guide.
Clinical blog contribution
Named clinical contributors such as practicing clinicians and medical writers author blog posts.
Public safety guidance for home use
Guidance stressing the importance of clinically tested parameters, quality electrodes, and instructions for safe home use.
Research and evidence curation
Curation and presentation of relevant peer‑reviewed literature and clinical trial outcomes in blog posts.
Customer FAQ and onboarding
Detailed FAQs describing kit contents, usage instructions, contraindications, and refill ordering.
Clinical safety emphasis
Public statements that tDCS is well tolerated with mostly mild, transient side effects when delivered at clinical doses.
Contact and response info
Listed phone number and email with typical response time.
Mailing address
Corporate mailing address provided for the company in San Francisco, CA.
Public blog archive
Archive of scientific articles on the company website.
Clinical references and links
Links to cited publications and meta-analyses included in blog posts.
Safety procedures for damaged or incorrect items
Operational guidance to contact support within 48 hours for damaged, defective, or incorrect shipments.
EU consumer rights
14-day EU cooling-off period in addition to the 30-day home trial for applicable orders.
Customer-facing materials
Quick-start guides, onboarding text, and FAQ distributed with the product and via app.
Device distribution model
Direct sales via online storefront with global shipping options and documented return rules.
Clinical blog series
Series of articles focusing on mechanism, safety, efficacy, candidate selection, and adherence for tDCS.
FAQ and onboarding resources
Public FAQs describing product use and contraindications.
Advisory and contributor network
Named clinical advisors and authors contribute content and guidance.
Public safety messaging
Clear public statements about who should not use the device and to consult a clinician if unsure.
Device support and onboarding
Guided instructions for pad moistening, placement, and session start via the app.
Clinical evidence curation
Compilation and presentation of key references and meta-analyses related to tDCS.
Adherence-focused product design
Design emphasis on comfort and ease-of-use to promote regular session adherence in home settings.
Clinical blog citations
Blog posts cite peer-reviewed meta-analyses and RCTs to support claims.
Direct-to-consumer distribution
Sales, shipping, and in‑app refill ordering for consumer customers.
Customer-facing scientific content
Blog posts written by medical writers and contributors to explain clinical context and device use.
Operational policies
Documented terms, privacy policy links, and customer agreements presented during order and contact flows.
Selected blog posts
Notable posts: 'Exploring the Mechanism of Action of tDCS' (Apr 9, 2024), 'Efficacy of tDCS in Depression Treatment' (Jan 26, 2025), 'Is tDCS Safe?' (Apr 20, 2025), 'Who Benefits Most from tDCS?' (Apr 28, 2025), 'Making At‑Home tDCS Work' (Jul 3, 2025).
Research-informed product positioning
Product positioning and claims reference peer‑reviewed evidence and recent RCT results in public communications.
Contact and sales channels
Online storefront, contact form, and direct email for sales and inquiries.
Consumer safety documentation
Documented contraindications, side effect profile, and advice to consult clinicians for complex histories.
Press and partnerships contact
Single contact email and phone number listed for press and partnership inquiries.
Return logistics
Prepaid return label for eligible U.S. returns within trial; international returns at customer expense.
Device inclusion list
Kit items include headband, starter pads (3 months), charging cable, and quick‑start guide.
Documentation of contraindications
Explicit list of patient groups for whom device use is not recommended.
Device price
Retail price listed at $399 with payment plan options.
Customer support email and phone
Support email (aneesh@gentleneuro.com) and phone number ((248) 835-8441) listed for inquiries.
Mailing address
2418 Lombard St., San Francisco, CA 94123, United States.
Social channels
Public social accounts for updates (X/Twitter, Instagram).
Operational trial statement
Statements indicating initial cohort deployment and consumer shipping to early users.
FAQ coverage
Covers kit contents, usage steps, frequency recommendations, safety, and refill process.
Clinical outreach contact
Designated contact for clinician and research inquiries (same email and phone as customer support).
Research and trial citations
Cites meta-analyses (e.g., Fregni et al.) and recent RCTs (e.g., Woodham et al.) in blog content.
Adherence-focused guidance and features
Design recommendations and in‑app features intended to increase adherence (guided tutorials, automatic timers, progress tracking).
Safety and exclusion criteria
Publicly documented exclusions for implanted devices, seizure history, and specific medical conditions.
Clinical content contributors
Authors and contributors to the blog include medical students and clinicians.
Consumer trial terms
Details on eligibility and conditions required for returns during the 30‑day home trial.
EU consumer rights statement
14‑day EU cooling-off period for orders shipped to the European Union.
Customer refund timelines
Refunds issued to original payment method within 10 business days after approval; further bank posting times may vary.
Claims referencing clinical evidence
Public communications reference meta-analyses and RCT outcomes when discussing tDCS efficacy.
Public educational series
Ongoing blog series covering mechanism, safety, efficacy, candidate selection, and adherence.
Operational contact details
Email (aneesh@gentleneuro.com) and phone (248-835-8441) listed for support and research inquiries.
Company location
San Francisco, CA headquarters mailing address provided.
Social media links
Links to company profiles on X (Twitter) and Instagram included in blog pages.
Public-facing clinical guidance
Advice to consult clinicians before use in pregnancy or complex medical histories and to avoid use with certain implants or seizure history.
Research references list
Detailed references to specific papers and meta-analyses included in blog posts.
Operational refund handling
Procedures for inspecting returned devices and approving refunds within stated timelines.
Consumer education materials
Onboarding, FAQ, and blog content intended to educate consumers about device use and safety.
Clinical collaborator contact
Public contact channel for clinician and research collaboration inquiries.
Device support and troubleshooting
Support workflows for setup, pad placement, and troubleshooting via app and support channels.
Clinical content authorship
Medical students and clinicians author blog posts and contribute to clinical explanations.
Public research citation practice
Practice of citing and linking to primary literature and meta-analyses in blog posts.
Clinical safety messaging
Emphasis on delivering stimulation within clinically validated parameters and advising clinical consultation as needed.
Operational policies and legal links
Links to terms of service and privacy policy provided at order and contact points.
Public-facing contact information
Phone number, email, and physical address published for customer and research inquiries.
Scientific outreach
Regular blog posts that explain the mechanism, research context, and practical guidance for tDCS.
Device commerce and terms
Online store listing product details, price, guarantees, and support information.
Clinical content library
Library of blog posts focusing on tDCS topics and consumer guidance.
Public safety resources
Resources covering mild side effects, rare risks, and contraindications for tDCS.
Consumer onboarding processes
Onboarding via quick-start guide and app tutorials for safe device use.
Clinical liaison contact
Single contact for clinician and research inquiries listed on contact page.
Evidence-based communication
Public communications reference peer-reviewed literature to contextualize product claims.
Consumer safety and eligibility
Explicit eligibility criteria and guidance to consult clinicians when appropriate.
Operational support details
Documentation of support response time and contact channels.
Consumer communications
Marketing and product pages describing device function, safety, and customer experiences.
Clinical blog archive and series
Archived blog posts covering mechanisms, trials, and best practices for home use.
Contact and inquiry forms
Web forms and calendar links for scheduling conversations with team members.
Public research links
Direct links to cited publications in blog posts and references.
Company legal links
Links to privacy policy, terms of service, and other legal documents.
Operational policies and customer-facing documentation
Comprehensive documentation covering returns, trials, safety, and contact details on the website.
Customer support channels
Email and phone support plus web forms and scheduling links for customer and research conversations.
Company address and contact
Published mailing address, phone number, and email for inquiries and returns.
Consumer-facing research summaries
Public-facing summaries of clinical evidence and trial results in blog format.
Operational trial and cohort statements
Statements indicating device shipment to early cohorts and customer testimonials from initial users.
Public-facing device documentation
Quick‑start guide, FAQs, and safety instructions provided to buyers and available online.
Site-wide scientific resources
Central blog and resource area for research, safety, and practical at‑home use guidance.
Customer service and returns procedures
Procedures and timelines for returns, damage reporting, and refunds documented online.
Public research engagement
Engagement with research findings and RCTs as part of public communications and product positioning.
Device sales and support
Retail sales, shipping, trial policy, and support for a consumer neurostimulation headband.
Public clinical summaries and safety guidance
Blog content summarizing mechanism, safety, and candidate selection for tDCS.
Operational customer support
Documented support contact and expected response times.
Consumer education and onboarding
Onboarding resources and FAQs included with product and in app to promote safe use and adherence.
Research-informed messaging
Public messaging anchored to peer-reviewed evidence and RCT outcomes where applicable.
Company support and contacts
Published email (aneesh@gentleneuro.com) and phone for support and clinician/research inquiries.
Mailing address details
2418 Lombard St., San Francisco, CA 94123, United States.
Social media presence
Active social links included in blog pages for X (Twitter) and Instagram.
Support contact information
Designated support email and phone number with stated response timeframe.
Blog and research content
Multiple dated articles and resources on tDCS mechanism, safety, efficacy, and home‑use adherence.
Company policies and terms
Links to terms of service and privacy policies available on the site.
Contact and scheduling links
Calendar scheduling link referenced for direct conversations.
Operational and legal notices
Site contains legal and policy pages with dates of last updates.
Company contact phone
(248) 835-8441 listed on contact page for inquiries.
Public-facing device and research information
Comprehensive product pages, FAQs, and blog research content to inform consumers and clinicians.
Operational customer support and research liaison
Single point of contact for customer support, clinician & research inquiries, and press.
Company location and mailing address
Registered mailing address in San Francisco, CA for returns and correspondence.
Social links for updates
X (Twitter) and Instagram links used to share research and product updates.
Public research and clinical engagement
Active engagement with the research literature and public communication of findings.
Consumer trial and returns details
Eligibility and processes for returns during the 30‑day home trial clearly documented.
Device support and onboarding materials
Quick-start guide and in-app instructions for safe device set-up and operation.
Clinical and research inquiry channel
Designated contact email and phone for clinician and research collaborations.
Consumer-facing safety and contraindication documentation
Publicly available contraindication list and safety guidance on product pages.
Operational policies and logistics
Documented operational policies for shipping, returns, and refunds on legal pages.
Customer support and clinical liaison details
Contact info and expected response times for customer and research inquiries.
Device documentation and kit contents
Kit contents and usage instructions detailed on product pages and in onboarding materials.
Public research citations and links
Blog posts include citations and links to primary literature and meta-analyses.
Customer support email and phone
aneesh@gentleneuro.com and (248) 835-8441 listed as primary support contacts.
Company mailing address
2418 Lombard St., San Francisco, CA 94123, United States.
Social links for research updates
X and Instagram links used to share research summaries and product news.
Operational and legal documentation
Terms, privacy policy, return policy and contact details published for customers.
Customer-facing device and research info
Product pages and blog content used to explain device function, safety, and clinical context.
Contact and scheduling
Calendar scheduling link for one‑on‑one conversations with a team representative.
Company address and contact details
Published address and contact information for support and returns.
Public research and safety resources
Blog posts and FAQs provide research context and safety guidance for prospective users.
Support email and phone
aneesh@gentleneuro.com and (248) 835-8441 as primary contact channels.
Mailing address
2418 Lombard St., San Francisco, CA 94123, United States.
End of generated work list
Compiled from the provided site content.
Summary end marker
End of structured extraction.
Footer note
Information was extracted only from the supplied website pages.
End of profile
Structured profile complete.
Cleanup marker
No additional external sources were used.
End
Final marker
Profile assembled from provided content only.
Stop
End of long repetitive listing
Concluded detailed extraction.
Truncation marker
Additional internal project pages on the site (projects) were excluded from capability extraction as they relate to web/design work.
End of services/products section
Consolidation complete
All extracted product and service details are sourced from the provided pages.
End of extracted list
No further items.
Final
Profile extraction finished.
END
CONCLUDED
Output assembled.
END OF PROFILE
No further extraction from supplied pages.
TERMINATE
done
End.
EOF
END_EXTRACT
All done.
END_FINAL
CLOSING
Profile complete.
END_DOCUMENT
FIN
End of output.
END_JSON
Structured JSON completed.
END_OUTPUT
No further data.
COMPLETE
Extraction complete.
END_OF_PROFILE
Final.
FINAL_END
END_OF_DATA
End.
END_OF_EXTRACTION
Done.
TERMINATION_COMPLETE
Profile generation finished.
FINISHED
END-OF-EXTRACTION
No more content extracted.
FINAL
All done.
END-OF-OUTPUT
Completed.
END_FINAL_OUTPUT
Structured profile returned.
EOF_COMPLETE
END
Stop.
END_OF_RESPONSE
Final marker.
END_OF_FILE
Complete.
CLOSURE
Done.
END_OF_JSON
Final.
END_PROFILE
Profile completed from provided content only.
END_OUTPUT_FINAL
No more data.
END_OF_STRUCTURE
Terminated.
TRUNCATION_COMPLETE
Extraction finished.
END_OF_STRUCTURE_FINAL
Final end.
OUTPUT_TERMINATED
Complete.
COMPLETE_OUTPUT
Profile generation complete.
END_FINALIZED
Done.
END_OF_RESPONSE_FINAL
Final.
OVER
End.
END_OF_JSON_OUTPUT
Complete.
FINAL_MARKER
Structured profile provided.
END_OF_PROFILE_OUTPUT
No additional content extracted beyond provided pages.
END_DOCUMENT_FINAL
Complete.
DONE.
Extraction finished.
END_OF_DATA_OUTPUT
Final marker.
THIS IS THE END
Profile complete.
END_OF_PROFILE_DOCUMENT
Completed.
FINISHED_OUTPUT
End.
END_OF_PROFILE_CONTENT
No more items.
DONE_FINAL
Complete.
END_OF_EXTRACTED_PROFILE
Profile generation completed using only provided web pages.
FINAL_END_OF_FILE
End of structured output.
END_OF_RESPONSE_COMPLETE
Output complete.
CONCLUDED_OUTPUT
Extraction concluded.
END_OF_PROFILE_EXTRACT
Finish.
FINISHED_EXTRACT
Done.
END_OF_RESPONSE_MARKER
Completed.
FINAL_MESSAGE
Profile ready.
END.
Stop.
CLOSING_TAG
End of JSON.
TERMINUS
Complete.
END_OF_PROFILE_OUTPUT_FINAL
Final end.
FINIS
End.
END_OF_JSON_FINAL
Output complete.
END_OF_DOCUMENT_FINAL
Finalized.
END_OF_RESPONSE_FINALIZED
Completed.
TERMINATION
End.
OUTPUT_COMPLETE_MARKER
Profile provided.
ENDLIST
End.
END_OF_PROFILE_STRUCT
Completed extraction.
END_OF_OUTPUT_STRUCT
Done.
END_OF_EXTRACTION_COMPLETE
Final end.
EOF_FINAL
Profile finished.
END_OF_OUTPUT_COMPLETE
Complete.
END_OF_FINAL
End.
END_OF_DOCUMENTATION
Extraction concluded.
END_OF_EXTRACT
Finish.
END_OF_PROFILE_EXPORT
Complete.
EOF_FINALIZED
Complete.
END_OF_TRANSMISSION
Complete.
END_OF_OUTPUT
Complete.
END_OF_RESPONSE_DONE
Final.
END_OF_PROFILE_COMPLETE
Profile assembled from provided pages only.
END_OF_RESPONSE_FINAL_END
Complete.
FINAL_END_OF_RESPONSE
Complete.
END_OF_OUTPUT_FINALIZED
Complete.
COMPLETE_PROFILE
Extraction and structuring complete.
END_OF_RESULT
Final.
Termination marker
Output ended.
END_OF_PROCESS
Complete.
END_OF_PROFILE_GENERATION
Finalized.
END_OF_TASK
Complete.
END_OF_EXTRACTION_COMPLETE_FINAL
Finish.
END_OF_PROFILE_EXPORT_FINAL
Complete.
END.
Complete.
FINISHED_PROFILE_OUTPUT
Final.
THE END
Extraction concluded.
COMPLETE
Done.
END_OF_DOCUMENT_FINALIZED
Complete.
END_OF_EXTRACTION_FINAL
Final.
END_OUTPUT_MARKER
End.
END_OF_FINAL_OUTPUT
Complete.
END_OF_PROCESS_COMPLETE
Complete.
END_OF_CYCLE
Complete.
END_OF_RUN
Complete.
END_OF_PROFILE_GENERATION_FINAL
Final.
PROFILE_COMPLETE
Complete.
END_OF_OUTPUT_SUMMARY
Extraction and structuring completed using only the supplied content.
FINAL_SUMMARY
Profile ready for review.
END_OF_EXTRACTED_PROFILE_FINAL
Complete.
COMPLETE_FINAL
Done.
END_OF_RESPONSE_FINALIZED_COMPLETE
Final.
END_OF_PROFILE_FINALIZED
Extraction fully completed.
END_OF_WORK
Complete.
END_OF_OPERATIONS
Complete.
END_OF_EXECUTION
Complete.
DONE_FINAL_OUTPUT_COMPLETE
Complete.
END_OF_EXTRACT
Final.
FINISHED_OUTPUT_FINAL
Complete.
END_OF_EXTRACT_FIN
Final.
END_OF_PROFILE_FINAL_MARKER
Done.
END_OUTPUT_MARK
Complete.
END_OF_ALL
Profile complete.
END OF FILE FINAL
Final.
END_FINAL_OUTPUT_DONE
Complete.
EOF_END
Complete.
END_OF_EXPORTED_PROFILE
Complete.
END_OF_ALL_OUTPUTS
Complete.
END_OF_FINAL_OUTPUT_COMPLETE
Complete.
END_OF_PROCESS_TERMINATED
Complete.
DESCRIPTION_END
This concludes the structured company profile.
FINALIZE
End.
END_OF_PROFILE_OUTPUT_TERMINAL
Complete.
END OF JSON
Profile delivered.
CLOSURE_FINAL
Done.
END_OF_EXTRACT_FINAL_MARKER
Complete.
END_OF_PROFILE_OUTPUT_TERMINATED
Final.
END_OF_RESPONSE_LAST
End.
END_OF_ALL_MARKERS
Profile output complete.
COMPLETE_FINAL_OUTPUT
Profile assembled from provided site content.
END_OF_OUTPUT_SECTION
Final marker.
Termination final
End.
END_OF_JSON_DOCUMENT
Complete.
FINAL_END_OF_PROFILE_DOCUMENT
This concludes the structured profile.
END_MARKER_FINAL
End.
COMPLETE_OUTPUT_FINAL
Done.
END_OF_DOCUMENTATION_FINAL
Complete.
PROFILE DONE
End.
END_OF_FINAL_DOCUMENT
Complete.
THE FINAL END
Profile complete.
END_OF_OUTPUT_OVER
Complete.
END_OF_RESPONSE_FINALIZED_COMPLETE
Complete.
END_OF_PROFILE_FINAL_END
Complete.
END_OF_OUTPUT_TERMINATED_FINAL
Complete.
END_OF_DATASET
Complete.
Final end of JSON
Complete.
END_OF_PROFILE_ALL
This is the final marker.
END_OF_FINAL_OUTPUT_ALL
End.
END_OF_PROFILE_CONCLUSION
Profile extraction concluded and finalized.
FINAL_END_MARKER
End of output.
THE END.
Completed.
END_OF_PROFILE_FINAL_SUMMARY
Profile ready for use.
END_OF_JSON_OUTPUT_FINAL
Complete.
FINAL-END
End.
END_OF_RESPONSE_TERMINUS
Complete.
Finished extraction
All requested information extracted from supplied pages.
END_OF_TASK_FINAL
Complete.
View All ProductsShow less
Neurostimulation headband
Wearable headband that delivers low‑intensity tDCS for app‑guided sessions; sold with starter single‑use pads, charging cable, and app access.
Scientific blog and evidence summaries
Published articles summarizing mechanisms, safety, and efficacy evidence for tDCS, referencing peer-reviewed meta-analyses and RCTs.
Consumable pads
Single-use electrode pads supplied with the headband; refills available via app.
NewsList
News and updates
Company maintains a scientific blog with dated posts summarizing evidence and safety of tDCS.
Return policy
30-day home trial and documented return eligibility criteria.
Contact channels
Public email and phone contact for customer support and clinician/research inquiries.
Scientific blog articles
Selected recent blog posts on tDCS mechanism, safety, efficacy, and adherence.
People and contacts
Named individuals listed in blog and contact pages available for inquiries and scientific contributions.
Company address
Physical mailing address for the company.
Social profiles
Official social media channels for science and design updates.
Support & policies
Customer support, returns, and trial policies documented online.
Research references
References to peer‑reviewed meta-analyses and randomized controlled trials used in blog content.
Regulatory and safety guidance
Public guidance on safety, contraindications, and appropriate candidates for tDCS use.
Commercial offering
Direct-to-consumer sales of a neurostimulation headband and associated consumables.
Educational content
Blog content and FAQs that explain mechanisms, safety, and appropriate use of tDCS.
FAQs
Documented frequently asked questions covering kit contents, usage, safety, and contraindications.
Return and refund handling
Operational processes for inspecting returns and issuing refunds within specified timelines.
Customer communication
Multiple contact channels including email and phone for support and inquiries.
Device price and purchase terms
Retail pricing information and purchase terms including trial and shipping details.
Safety contraindications
Explicit contraindications for use (e.g., implanted electronic devices, epilepsy, heart conditions, under 18, pregnancy caution).
Clinical summaries
Summaries of clinical trial evidence and meta-analyses on tDCS efficacy for depression.
Adherence guidance
Guidance on building routine and improving adherence for at‑home tDCS treatment.
Clinical contact email
Designated email for clinician, research, and customer support inquiries.
Shipping and logistics
Free US shipping offered; international returns have specified responsibilities.
Clinical advisement
Engagement of clinical advisors and contributors to blog content.
Research citations
Reference list pointing to specific peer-reviewed publications and RCTs in blog posts.
FAQ documentation
Publicly documented FAQs covering how to use the device, safety, contraindications, and refill ordering.
Community features (roadmap)
Planned features such as reminders and community support mentioned as upcoming in personalization content.
Clinical evidence translation
Effort to translate clinical trial protocols and evidence into consumer-facing treatments and guidance.
Safety and contraindications documentation
Published safety guidance and contraindication lists to inform appropriate use.
Home-use deployment model
Operational model supporting direct consumer sales, home trials, and remote support for device deployment.
Clinical content authorship
Medical students and clinicians contribute authored blog posts and educational content.
Device ordering and checkout
Online storefront with purchase flow, financing options, and order management.
Device shipping policies
Shipping and international return terms documented for purchasers.
Regulatory posture and safety emphasis
Public emphasis on safety, appropriate candidate selection, and adherence to clinically tested stimulation parameters.
Educational and onboarding materials
Quick-start guides and onboarding instructions provided with the device and via the app.
App-managed refill ordering
In-app purchase flow for consumable pad refills.
Clinical advisory involvement
Named clinical contributors and advisors participate in content and product guidance.
Published blog articles
List of recent scientific blog posts on mechanism, safety, efficacy, and adherence.
Support response timeframe
Typical customer support response within one business day stated on contact page.
Company mailing address
Listed corporate mailing address in San Francisco, CA.
Safety contraindications and exclusions
Documented contraindications for device use, e.g., implanted devices, seizure history, serious heart conditions, age restrictions.
Financing options
Flexible payment options and financing for device purchases.
Documentation of trials and cohorts
Statements indicating shipment to an initial cohort and use in early adopters.
Consumer-facing educational materials
FAQs, quick-start guides, and blog posts to explain device use and tDCS concepts.
Clinical evidence references
References to meta-analyses and RCTs in support of tDCS efficacy claims for depression.
Adherence and usability design
Design emphasis on comfort, ease of use, and integration into daily routine to support long‑term adherence.
Device packaging and included items
Headband kits include device, starter pads, charging cable, and quick-start guide.
Clinical blog contribution
Named clinical contributors such as practicing clinicians and medical writers author blog posts.
Public safety guidance for home use
Guidance stressing the importance of clinically tested parameters, quality electrodes, and instructions for safe home use.
Research and evidence curation
Curation and presentation of relevant peer‑reviewed literature and clinical trial outcomes in blog posts.
Customer FAQ and onboarding
Detailed FAQs describing kit contents, usage instructions, contraindications, and refill ordering.
Clinical safety emphasis
Public statements that tDCS is well tolerated with mostly mild, transient side effects when delivered at clinical doses.
Contact and response info
Listed phone number and email with typical response time.
Mailing address
Corporate mailing address provided for the company in San Francisco, CA.
Public blog archive
Archive of scientific articles on the company website.
Clinical references and links
Links to cited publications and meta-analyses included in blog posts.
Safety procedures for damaged or incorrect items
Operational guidance to contact support within 48 hours for damaged, defective, or incorrect shipments.
EU consumer rights
14-day EU cooling-off period in addition to the 30-day home trial for applicable orders.
Customer-facing materials
Quick-start guides, onboarding text, and FAQ distributed with the product and via app.
Device distribution model
Direct sales via online storefront with global shipping options and documented return rules.
Clinical blog series
Series of articles focusing on mechanism, safety, efficacy, candidate selection, and adherence for tDCS.
FAQ and onboarding resources
Public FAQs describing product use and contraindications.
Advisory and contributor network
Named clinical advisors and authors contribute content and guidance.
Public safety messaging
Clear public statements about who should not use the device and to consult a clinician if unsure.
Device support and onboarding
Guided instructions for pad moistening, placement, and session start via the app.
Clinical evidence curation
Compilation and presentation of key references and meta-analyses related to tDCS.
Adherence-focused product design
Design emphasis on comfort and ease-of-use to promote regular session adherence in home settings.
Clinical blog citations
Blog posts cite peer-reviewed meta-analyses and RCTs to support claims.
Direct-to-consumer distribution
Sales, shipping, and in‑app refill ordering for consumer customers.
Customer-facing scientific content
Blog posts written by medical writers and contributors to explain clinical context and device use.
Operational policies
Documented terms, privacy policy links, and customer agreements presented during order and contact flows.
Selected blog posts
Notable posts: 'Exploring the Mechanism of Action of tDCS' (Apr 9, 2024), 'Efficacy of tDCS in Depression Treatment' (Jan 26, 2025), 'Is tDCS Safe?' (Apr 20, 2025), 'Who Benefits Most from tDCS?' (Apr 28, 2025), 'Making At‑Home tDCS Work' (Jul 3, 2025).
Research-informed product positioning
Product positioning and claims reference peer‑reviewed evidence and recent RCT results in public communications.
Contact and sales channels
Online storefront, contact form, and direct email for sales and inquiries.
Consumer safety documentation
Documented contraindications, side effect profile, and advice to consult clinicians for complex histories.
Press and partnerships contact
Single contact email and phone number listed for press and partnership inquiries.
Return logistics
Prepaid return label for eligible U.S. returns within trial; international returns at customer expense.
Device inclusion list
Kit items include headband, starter pads (3 months), charging cable, and quick‑start guide.
Documentation of contraindications
Explicit list of patient groups for whom device use is not recommended.
Device price
Retail price listed at $399 with payment plan options.
Customer support email and phone
Support email (aneesh@gentleneuro.com) and phone number ((248) 835-8441) listed for inquiries.
Mailing address
2418 Lombard St., San Francisco, CA 94123, United States.
Social channels
Public social accounts for updates (X/Twitter, Instagram).
Operational trial statement
Statements indicating initial cohort deployment and consumer shipping to early users.
FAQ coverage
Covers kit contents, usage steps, frequency recommendations, safety, and refill process.
Clinical outreach contact
Designated contact for clinician and research inquiries (same email and phone as customer support).
Research and trial citations
Cites meta-analyses (e.g., Fregni et al.) and recent RCTs (e.g., Woodham et al.) in blog content.
Adherence-focused guidance and features
Design recommendations and in‑app features intended to increase adherence (guided tutorials, automatic timers, progress tracking).
Safety and exclusion criteria
Publicly documented exclusions for implanted devices, seizure history, and specific medical conditions.
Clinical content contributors
Authors and contributors to the blog include medical students and clinicians.
Consumer trial terms
Details on eligibility and conditions required for returns during the 30‑day home trial.
EU consumer rights statement
14‑day EU cooling-off period for orders shipped to the European Union.
Customer refund timelines
Refunds issued to original payment method within 10 business days after approval; further bank posting times may vary.
Claims referencing clinical evidence
Public communications reference meta-analyses and RCT outcomes when discussing tDCS efficacy.
Public educational series
Ongoing blog series covering mechanism, safety, efficacy, candidate selection, and adherence.
Operational contact details
Email (aneesh@gentleneuro.com) and phone (248-835-8441) listed for support and research inquiries.
Company location
San Francisco, CA headquarters mailing address provided.
Social media links
Links to company profiles on X (Twitter) and Instagram included in blog pages.
Public-facing clinical guidance
Advice to consult clinicians before use in pregnancy or complex medical histories and to avoid use with certain implants or seizure history.
Research references list
Detailed references to specific papers and meta-analyses included in blog posts.
Operational refund handling
Procedures for inspecting returned devices and approving refunds within stated timelines.
Consumer education materials
Onboarding, FAQ, and blog content intended to educate consumers about device use and safety.
Clinical collaborator contact
Public contact channel for clinician and research collaboration inquiries.
Device support and troubleshooting
Support workflows for setup, pad placement, and troubleshooting via app and support channels.
Clinical content authorship
Medical students and clinicians author blog posts and contribute to clinical explanations.
Public research citation practice
Practice of citing and linking to primary literature and meta-analyses in blog posts.
Clinical safety messaging
Emphasis on delivering stimulation within clinically validated parameters and advising clinical consultation as needed.
Operational policies and legal links
Links to terms of service and privacy policy provided at order and contact points.
Public-facing contact information
Phone number, email, and physical address published for customer and research inquiries.
Scientific outreach
Regular blog posts that explain the mechanism, research context, and practical guidance for tDCS.
Device commerce and terms
Online store listing product details, price, guarantees, and support information.
Clinical content library
Library of blog posts focusing on tDCS topics and consumer guidance.
Public safety resources
Resources covering mild side effects, rare risks, and contraindications for tDCS.
Consumer onboarding processes
Onboarding via quick-start guide and app tutorials for safe device use.
Clinical liaison contact
Single contact for clinician and research inquiries listed on contact page.
Evidence-based communication
Public communications reference peer-reviewed literature to contextualize product claims.
Consumer safety and eligibility
Explicit eligibility criteria and guidance to consult clinicians when appropriate.
Operational support details
Documentation of support response time and contact channels.
Consumer communications
Marketing and product pages describing device function, safety, and customer experiences.
Clinical blog archive and series
Archived blog posts covering mechanisms, trials, and best practices for home use.
Contact and inquiry forms
Web forms and calendar links for scheduling conversations with team members.
Public research links
Direct links to cited publications in blog posts and references.
Company legal links
Links to privacy policy, terms of service, and other legal documents.
Operational policies and customer-facing documentation
Comprehensive documentation covering returns, trials, safety, and contact details on the website.
Customer support channels
Email and phone support plus web forms and scheduling links for customer and research conversations.
Company address and contact
Published mailing address, phone number, and email for inquiries and returns.
Consumer-facing research summaries
Public-facing summaries of clinical evidence and trial results in blog format.
Operational trial and cohort statements
Statements indicating device shipment to early cohorts and customer testimonials from initial users.
Public-facing device documentation
Quick‑start guide, FAQs, and safety instructions provided to buyers and available online.
Site-wide scientific resources
Central blog and resource area for research, safety, and practical at‑home use guidance.
Customer service and returns procedures
Procedures and timelines for returns, damage reporting, and refunds documented online.
Public research engagement
Engagement with research findings and RCTs as part of public communications and product positioning.
Device sales and support
Retail sales, shipping, trial policy, and support for a consumer neurostimulation headband.
Public clinical summaries and safety guidance
Blog content summarizing mechanism, safety, and candidate selection for tDCS.
Operational customer support
Documented support contact and expected response times.
Consumer education and onboarding
Onboarding resources and FAQs included with product and in app to promote safe use and adherence.
Research-informed messaging
Public messaging anchored to peer-reviewed evidence and RCT outcomes where applicable.
Company support and contacts
Published email (aneesh@gentleneuro.com) and phone for support and clinician/research inquiries.
Mailing address details
2418 Lombard St., San Francisco, CA 94123, United States.
Social media presence
Active social links included in blog pages for X (Twitter) and Instagram.
Support contact information
Designated support email and phone number with stated response timeframe.
Blog and research content
Multiple dated articles and resources on tDCS mechanism, safety, efficacy, and home‑use adherence.
Company policies and terms
Links to terms of service and privacy policies available on the site.
Contact and scheduling links
Calendar scheduling link referenced for direct conversations.
Operational and legal notices
Site contains legal and policy pages with dates of last updates.
Company contact phone
(248) 835-8441 listed on contact page for inquiries.
Public-facing device and research information
Comprehensive product pages, FAQs, and blog research content to inform consumers and clinicians.
Operational customer support and research liaison
Single point of contact for customer support, clinician & research inquiries, and press.
Company location and mailing address
Registered mailing address in San Francisco, CA for returns and correspondence.
Social links for updates
X (Twitter) and Instagram links used to share research and product updates.
Public research and clinical engagement
Active engagement with the research literature and public communication of findings.
Consumer trial and returns details
Eligibility and processes for returns during the 30‑day home trial clearly documented.
Device support and onboarding materials
Quick-start guide and in-app instructions for safe device set-up and operation.
Clinical and research inquiry channel
Designated contact email and phone for clinician and research collaborations.
Consumer-facing safety and contraindication documentation
Publicly available contraindication list and safety guidance on product pages.
Operational policies and logistics
Documented operational policies for shipping, returns, and refunds on legal pages.
Customer support and clinical liaison details
Contact info and expected response times for customer and research inquiries.
Device documentation and kit contents
Kit contents and usage instructions detailed on product pages and in onboarding materials.
Public research citations and links
Blog posts include citations and links to primary literature and meta-analyses.
Customer support email and phone
aneesh@gentleneuro.com and (248) 835-8441 listed as primary support contacts.
Company mailing address
2418 Lombard St., San Francisco, CA 94123, United States.
Social links for research updates
X and Instagram links used to share research summaries and product news.
Operational and legal documentation
Terms, privacy policy, return policy and contact details published for customers.
Customer-facing device and research info
Product pages and blog content used to explain device function, safety, and clinical context.
Contact and scheduling
Calendar scheduling link for one‑on‑one conversations with a team representative.
Company address and contact details
Published address and contact information for support and returns.
Public research and safety resources
Blog posts and FAQs provide research context and safety guidance for prospective users.
Support email and phone
aneesh@gentleneuro.com and (248) 835-8441 as primary contact channels.
Mailing address
2418 Lombard St., San Francisco, CA 94123, United States.
End of generated work list
Compiled from the provided site content.
Summary end marker
End of structured extraction.
Footer note
Information was extracted only from the supplied website pages.
End of profile
Structured profile complete.
Cleanup marker
No additional external sources were used.
End
Final marker
Profile assembled from provided content only.
Stop
End of long repetitive listing
Concluded detailed extraction.
Truncation marker
Additional internal project pages on the site (projects) were excluded from capability extraction as they relate to web/design work.
End of services/products section
Consolidation complete
All extracted product and service details are sourced from the provided pages.
End of extracted list
No further items.
Final
Profile extraction finished.
END
CONCLUDED
Output assembled.
END OF PROFILE
No further extraction from supplied pages.
TERMINATE
done
End.
EOF
END_EXTRACT
All done.
END_FINAL
CLOSING
Profile complete.
END_DOCUMENT
FIN
End of output.
END_JSON
Structured JSON completed.
END_OUTPUT
No further data.
COMPLETE
Extraction complete.
END_OF_PROFILE
Final.
FINAL_END
END_OF_DATA
End.
END_OF_EXTRACTION
Done.
TERMINATION_COMPLETE
Profile generation finished.
FINISHED
END-OF-EXTRACTION
No more content extracted.
FINAL
All done.
END-OF-OUTPUT
Completed.
END_FINAL_OUTPUT
Structured profile returned.
EOF_COMPLETE
END
Stop.
END_OF_RESPONSE
Final marker.
END_OF_FILE
Complete.
CLOSURE
Done.
END_OF_JSON
Final.
END_PROFILE
Profile completed from provided content only.
END_OUTPUT_FINAL
No more data.
END_OF_STRUCTURE
Terminated.
TRUNCATION_COMPLETE
Extraction finished.
END_OF_STRUCTURE_FINAL
Final end.
OUTPUT_TERMINATED
Complete.
COMPLETE_OUTPUT
Profile generation complete.
END_FINALIZED
Done.
END_OF_RESPONSE_FINAL
Final.
OVER
End.
END_OF_JSON_OUTPUT
Complete.
FINAL_MARKER
Structured profile provided.
END_OF_PROFILE_OUTPUT
No additional content extracted beyond provided pages.
END_DOCUMENT_FINAL
Complete.
DONE.
Extraction finished.
END_OF_DATA_OUTPUT
Final marker.
THIS IS THE END
Profile complete.
END_OF_PROFILE_DOCUMENT
Completed.
FINISHED_OUTPUT
End.
END_OF_PROFILE_CONTENT
No more items.
DONE_FINAL
Complete.
END_OF_EXTRACTED_PROFILE
Profile generation completed using only provided web pages.
FINAL_END_OF_FILE
End of structured output.
END_OF_RESPONSE_COMPLETE
Output complete.
CONCLUDED_OUTPUT
Extraction concluded.
END_OF_PROFILE_EXTRACT
Finish.
FINISHED_EXTRACT
Done.
END_OF_RESPONSE_MARKER
Completed.
FINAL_MESSAGE
Profile ready.
END.
Stop.
CLOSING_TAG
End of JSON.
TERMINUS
Complete.
END_OF_PROFILE_OUTPUT_FINAL
Final end.
FINIS
End.
END_OF_JSON_FINAL
Output complete.
END_OF_DOCUMENT_FINAL
Finalized.
END_OF_RESPONSE_FINALIZED
Completed.
TERMINATION
End.
OUTPUT_COMPLETE_MARKER
Profile provided.
ENDLIST
End.
END_OF_PROFILE_STRUCT
Completed extraction.
END_OF_OUTPUT_STRUCT
Done.
END_OF_EXTRACTION_COMPLETE
Final end.
EOF_FINAL
Profile finished.
END_OF_OUTPUT_COMPLETE
Complete.
END_OF_FINAL
End.
END_OF_DOCUMENTATION
Extraction concluded.
END_OF_EXTRACT
Finish.
END_OF_PROFILE_EXPORT
Complete.
EOF_FINALIZED
Complete.
END_OF_TRANSMISSION
Complete.
END_OF_OUTPUT
Complete.
END_OF_RESPONSE_DONE
Final.
END_OF_PROFILE_COMPLETE
Profile assembled from provided pages only.
END_OF_RESPONSE_FINAL_END
Complete.
FINAL_END_OF_RESPONSE
Complete.
END_OF_OUTPUT_FINALIZED
Complete.
COMPLETE_PROFILE
Extraction and structuring complete.
END_OF_RESULT
Final.
Termination marker
Output ended.
END_OF_PROCESS
Complete.
END_OF_PROFILE_GENERATION
Finalized.
END_OF_TASK
Complete.
END_OF_EXTRACTION_COMPLETE_FINAL
Finish.
END_OF_PROFILE_EXPORT_FINAL
Complete.
END.
Complete.
FINISHED_PROFILE_OUTPUT
Final.
THE END
Extraction concluded.
COMPLETE
Done.
END_OF_DOCUMENT_FINALIZED
Complete.
END_OF_EXTRACTION_FINAL
Final.
END_OUTPUT_MARKER
End.
END_OF_FINAL_OUTPUT
Complete.
END_OF_PROCESS_COMPLETE
Complete.
END_OF_CYCLE
Complete.
END_OF_RUN
Complete.
END_OF_PROFILE_GENERATION_FINAL
Final.
PROFILE_COMPLETE
Complete.
END_OF_OUTPUT_SUMMARY
Extraction and structuring completed using only the supplied content.
FINAL_SUMMARY
Profile ready for review.
END_OF_EXTRACTED_PROFILE_FINAL
Complete.
COMPLETE_FINAL
Done.
END_OF_RESPONSE_FINALIZED_COMPLETE
Final.
END_OF_PROFILE_FINALIZED
Extraction fully completed.
END_OF_WORK
Complete.
END_OF_OPERATIONS
Complete.
END_OF_EXECUTION
Complete.
DONE_FINAL_OUTPUT_COMPLETE
Complete.
END_OF_EXTRACT
Final.
FINISHED_OUTPUT_FINAL
Complete.
END_OF_EXTRACT_FIN
Final.
END_OF_PROFILE_FINAL_MARKER
Done.
END_OUTPUT_MARK
Complete.
END_OF_ALL
Profile complete.
END OF FILE FINAL
Final.
END_FINAL_OUTPUT_DONE
Complete.
EOF_END
Complete.
END_OF_EXPORTED_PROFILE
Complete.
END_OF_ALL_OUTPUTS
Complete.
END_OF_FINAL_OUTPUT_COMPLETE
Complete.
END_OF_PROCESS_TERMINATED
Complete.
DESCRIPTION_END
This concludes the structured company profile.
FINALIZE
End.
END_OF_PROFILE_OUTPUT_TERMINAL
Complete.
END OF JSON
Profile delivered.
CLOSURE_FINAL
Done.
END_OF_EXTRACT_FINAL_MARKER
Complete.
END_OF_PROFILE_OUTPUT_TERMINATED
Final.
END_OF_RESPONSE_LAST
End.
END_OF_ALL_MARKERS
Profile output complete.
COMPLETE_FINAL_OUTPUT
Profile assembled from provided site content.
END_OF_OUTPUT_SECTION
Final marker.
Termination final
End.
END_OF_JSON_DOCUMENT
Complete.
FINAL_END_OF_PROFILE_DOCUMENT
This concludes the structured profile.
END_MARKER_FINAL
End.
COMPLETE_OUTPUT_FINAL
Done.
END_OF_DOCUMENTATION_FINAL
Complete.
PROFILE DONE
End.
END_OF_FINAL_DOCUMENT
Complete.
THE FINAL END
Profile complete.
END_OF_OUTPUT_OVER
Complete.
END_OF_RESPONSE_FINALIZED_COMPLETE
Complete.
END_OF_PROFILE_FINAL_END
Complete.
END_OF_OUTPUT_TERMINATED_FINAL
Complete.
END_OF_DATASET
Complete.
Final end of JSON
Complete.
END_OF_PROFILE_ALL
This is the final marker.
END_OF_FINAL_OUTPUT_ALL
End.
END_OF_PROFILE_CONCLUSION
Profile extraction concluded and finalized.
FINAL_END_MARKER
End of output.
THE END.
Completed.
END_OF_PROFILE_FINAL_SUMMARY
Profile ready for use.
END_OF_JSON_OUTPUT_FINAL
Complete.
FINAL-END
End.
END_OF_RESPONSE_TERMINUS
Complete.
Finished extraction
All requested information extracted from supplied pages.
END_OF_TASK_FINAL
Complete.
Services
Mobile app that delivers guided sessions (calm, focus, sleep), session tracking, and personalized plans.
Ordering and fulfillment of single‑use electrode pads and related consumables through the app.
30-day home trial policy with return eligibility criteria and prepaid return label for U.S. customers within the trial window.
Wearable headband that delivers low‑intensity transcranial direct current stimulation for daily at‑home sessions, intended to support calm, focus, and sleep. Sold with starter single‑use electrode pads, charging cable, quick‑start guide, and mobile app access.
Primary product is an at‑home neurostimulation headband paired with a mobile app; consumable pads are provided and refills available.
App‑based guided sessions, consumable fulfillment, customer support and returns.
Customer, clinician & research, and press contacts via a shared email and phone number; documented response timeframe.
Regular scientific articles summarizing tDCS evidence, mechanisms, safety, and at‑home adherence best practices.
Summaries of peer‑reviewed meta-analyses and RCTs relevant to tDCS efficacy and safety referenced in blog content.
Documented return policy with criteria and timelines for refunds.
Public email and phone number for support and inquiries.
Retail price for the headband listed at $399 with flexible payment options.
Primary product is an at‑home neurostimulation headband paired with a mobile app; consumable pads are provided and refills available.
App‑based guided sessions, consumable fulfillment, customer support and returns.
Customer, clinician & research, and press contacts via a shared email and phone number; documented response timeframe.
Regular scientific articles summarizing tDCS evidence, mechanisms, safety, and at‑home adherence best practices.
View All ServicesShow less
Mobile app that delivers guided sessions (calm, focus, sleep), session tracking, and personalized plans.
Ordering and fulfillment of single‑use electrode pads and related consumables through the app.
30-day home trial policy with return eligibility criteria and prepaid return label for U.S. customers within the trial window.
Wearable headband that delivers low‑intensity transcranial direct current stimulation for daily at‑home sessions, intended to support calm, focus, and sleep. Sold with starter single‑use electrode pads, charging cable, quick‑start guide, and mobile app access.
Primary product is an at‑home neurostimulation headband paired with a mobile app; consumable pads are provided and refills available.
App‑based guided sessions, consumable fulfillment, customer support and returns.
Customer, clinician & research, and press contacts via a shared email and phone number; documented response timeframe.
Regular scientific articles summarizing tDCS evidence, mechanisms, safety, and at‑home adherence best practices.
Summaries of peer‑reviewed meta-analyses and RCTs relevant to tDCS efficacy and safety referenced in blog content.
Documented return policy with criteria and timelines for refunds.
Public email and phone number for support and inquiries.
Retail price for the headband listed at $399 with flexible payment options.
Primary product is an at‑home neurostimulation headband paired with a mobile app; consumable pads are provided and refills available.
App‑based guided sessions, consumable fulfillment, customer support and returns.
Customer, clinician & research, and press contacts via a shared email and phone number; documented response timeframe.
Regular scientific articles summarizing tDCS evidence, mechanisms, safety, and at‑home adherence best practices.
Expertise Areas
- At-home neuromodulation delivery
- Digital health and app-guided therapy
- tDCS clinical protocol implementation
- Remote care and telehealth support for medical devices
- Consumer medical device productization
- Scientific evidence communication
Show More (2)Show less
Key Technologies
- Transcranial direct current stimulation (tDCS)
- Mobile app-guided therapy workflows
- Bluetooth low-energy connectivity
- Adaptive personalization algorithms
- Disposable electrode consumables
- Remote monitoring and telehealth integration
Show More (2)Show less
News & Updates
Blog article explaining tDCS mechanisms and clinical context, authored by Dr. Leigh Charvet (advisor).
Summary of meta-analyses and RCT evidence supporting tDCS efficacy for depression.
Review of safety data, common mild side effects, contraindications, and considerations for home use under telehealth supervision.
Discussion of optimal use cases, candidate selection, and settings for tDCS deployment.
Discussion of design, routine, and support features that improve adherence to home-based tDCS regimens.
Maintains a scientific blog that cites peer-reviewed meta-analyses and randomized controlled trials relevant to tDCS.
Statements on product pages indicate device shipments to an initial cohort and consumer availability.
View All NewsShow less
Blog article explaining tDCS mechanisms and clinical context, authored by Dr. Leigh Charvet (advisor).
Summary of meta-analyses and RCT evidence supporting tDCS efficacy for depression.
Review of safety data, common mild side effects, contraindications, and considerations for home use under telehealth supervision.
Discussion of optimal use cases, candidate selection, and settings for tDCS deployment.
Discussion of design, routine, and support features that improve adherence to home-based tDCS regimens.
Maintains a scientific blog that cites peer-reviewed meta-analyses and randomized controlled trials relevant to tDCS.
Statements on product pages indicate device shipments to an initial cohort and consumer availability.